ZA946659B - 2(1h)-quinolone compounds process for preparing them and pharmaceutical compositions containing them - Google Patents

2(1h)-quinolone compounds process for preparing them and pharmaceutical compositions containing them

Info

Publication number
ZA946659B
ZA946659B ZA946659A ZA946659A ZA946659B ZA 946659 B ZA946659 B ZA 946659B ZA 946659 A ZA946659 A ZA 946659A ZA 946659 A ZA946659 A ZA 946659A ZA 946659 B ZA946659 B ZA 946659B
Authority
ZA
South Africa
Prior art keywords
substituted
branched
linear
unsubstituted
group
Prior art date
Application number
ZA946659A
Other languages
English (en)
Inventor
Alex Cordi
Patrice Desos
Jean Lepagnol
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of ZA946659B publication Critical patent/ZA946659B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • C07F9/5765Six-membered rings condensed with carbocyclic rings or carbocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • C07F9/60Quinoline or hydrogenated quinoline ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA946659A 1993-08-31 1994-08-31 2(1h)-quinolone compounds process for preparing them and pharmaceutical compositions containing them ZA946659B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9310379A FR2709489B1 (fr) 1993-08-31 1993-08-31 Nouveaux dérivés de 2-(1H)-quinoléinone, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.

Publications (1)

Publication Number Publication Date
ZA946659B true ZA946659B (en) 1995-04-20

Family

ID=9450460

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA946659A ZA946659B (en) 1993-08-31 1994-08-31 2(1h)-quinolone compounds process for preparing them and pharmaceutical compositions containing them

Country Status (12)

Country Link
US (2) US5536709A (de)
EP (1) EP0640612B1 (de)
JP (1) JP2672262B2 (de)
AT (1) ATE165362T1 (de)
AU (1) AU676348B2 (de)
CA (1) CA2117600A1 (de)
DE (1) DE69409734T2 (de)
DK (1) DK0640612T3 (de)
ES (1) ES2118343T3 (de)
FR (1) FR2709489B1 (de)
NZ (1) NZ264338A (de)
ZA (1) ZA946659B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000309585A (ja) * 1999-02-26 2000-11-07 Kyorin Pharmaceut Co Ltd 6−置換ヘテロキノリンカルボン酸誘導体とその付加塩及びそれらの製造方法
FR2805261A1 (fr) * 2000-02-18 2001-08-24 Adir Nouveaux derives d'acides 6-amino ou 6-hydrazinosulfonyl-3- quinolinyl phosphoniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2805262A1 (fr) * 2000-02-18 2001-08-24 Adir Nouveaux derives d'acides aryle ou heteroaryle quinolinyl phosphoniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2805260A1 (fr) * 2000-02-18 2001-08-24 Adir Nouveaux derives d'acides 6-sulfamoyl-3-quinolinyl phosphoniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
TWI366565B (en) 2007-06-06 2012-06-21 Otsuka Pharma Co Ltd Quinolone compound and pharmaceutical composition
CN101827599B (zh) * 2007-10-16 2013-08-28 詹森药业有限公司 用于合成膦酸和次膦酸化合物的方法
WO2012164085A1 (en) 2011-06-03 2012-12-06 Merz Pharma Gmbh & Co. Kgaa Glycine b antagonists

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4124588A (en) * 1976-03-01 1978-11-07 Sandoz, Inc. 4-Hydroxy-quinolin-2-one-3-phosphonic acid esters
US4093637A (en) * 1977-01-31 1978-06-06 The United States Of America As Represented By The Secretary Of Agriculture Alkyl 9,9(10,10)-bis(acyloxymethyl)octadecanoates as primary plasticizers for polyvinylchloride
US4906621A (en) * 1985-05-24 1990-03-06 Ciba-Geigy Corporation Certain 2-carboxypiperidyl-alkylene phosphonic acids and esters thereof useful for the treatment of disorders responsive to N-methyl-D-aspartate receptor blockade
FR2683818B1 (fr) * 1991-11-14 1993-12-31 Adir Cie Nouveaux derives de 3-sulfonylamino-2-(1h)-quinoleinone, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
IS4233A (is) * 1993-12-22 1995-06-23 Astra Aktiebolag Misleit hringtengd efnasambönd

Also Published As

Publication number Publication date
EP0640612B1 (de) 1998-04-22
CA2117600A1 (fr) 1995-03-01
JP2672262B2 (ja) 1997-11-05
FR2709489B1 (fr) 1995-10-20
DK0640612T3 (da) 1999-02-15
ATE165362T1 (de) 1998-05-15
FR2709489A1 (fr) 1995-03-10
AU7152094A (en) 1995-03-16
NZ264338A (en) 1995-10-26
JPH07149778A (ja) 1995-06-13
US5536709A (en) 1996-07-16
EP0640612A1 (de) 1995-03-01
AU676348B2 (en) 1997-03-06
US5646132A (en) 1997-07-08
DE69409734D1 (de) 1998-05-28
ES2118343T3 (es) 1998-09-16
DE69409734T2 (de) 1998-11-12

Similar Documents

Publication Publication Date Title
HK57197A (en) Naphthalene derivatives procedure for their preparation and pharmaceutical compositions containing them
ATE79376T1 (de) Dithioacetal-verbindungen, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
PH23607A (en) Amide derivatives and pharmaceutical composition containing said compounds
DE3271269D1 (en) Benzimidazole derivatives, process for the preparation thereof and pharmaceutical composition containing the same
ES445660A1 (es) Procedimiento para preparar acidos w-acetileno-w-amino-alca-noicos y 2-alquenoicos.
ZA928727B (en) 3-sulfonylamino-2(1H)-quinolone compounds, process for preparing them and pharmaceutical compositions containing them.
AU8824391A (en) New guanidine compounds, process for preparing these and pharmaceutical compositions containing them
EP0228845A3 (en) N-containing heterocyclic compounds, processes for the preparation thereof and composition comprising the same
ZA946659B (en) 2(1h)-quinolone compounds process for preparing them and pharmaceutical compositions containing them
ES2011075A6 (es) Procedimiento de obtencion de nuevas 3-(2-haloalquil)-1, 4-oxatiinas y2- (2-haloalquil) -1,4-ditiinas utiles en el tratamiento de leucemia y otros tumores.
IN162570B (de)
EP0123146A3 (en) Compounds with antiinflammatory activity, process for preparation thereof and pharmaceutical compositions therefrom
IL88641A0 (en) Aminoalkyl ketone or alcohol derivatives,their preparation and pharmaceutical compositions comprising them
IL106564A (en) Tetrahydronaphthalene derivatives their preparation and pharmaceutical compositions containing them
ES8105286A1 (es) Un procedimiento para la preparacion de nuevos derivados de dihidropiridina.
ZA872925B (en) Heterocyclic compounds